| Code | 8461E | ||||||||||
| MA number | 44/0001/25-S | ||||||||||
| Product Form: | tbl flm 112x40 mg (blis.Al-OPA/Al/PVC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 04.02.2025 |
| Validity: | 04.02.2030 |
| SPC: |
SPC_Enzalutamide STADA 40 mg_02.2025.pdf
|
| PIL: |
PIL_Enzalutamide STADA 40 mg_02.2025.pdf
|
| Safety feature | Yes |
| Data update: | 11.02.2025 |
